trimetazidine has been researched along with Inflammation in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 8 (47.06) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Chen, B; Dai, C; Li, J; Li, Y; Qi, Y; Wang, J | 1 |
| Arıcı, T; Barut, EN; Engin, S; Kadıoğlu, M; Kerimoğlu, G; Sezen, SF; Soysal, AÇ; Yaşar, YK | 1 |
| El-Khodary, NM; El-Tayaar, AA; El-Touny, EM; Ghoneim, AI | 1 |
| Arpa, M; Deniz, E; Duman Ozturk, S; Kutlu Yilmaz, E; Ozturk, A; Topcu, A | 1 |
| Ji, N; Sheng, Y; Wang, Y; Zhang, H | 1 |
| Mallick, S; Mohapatra, S; Nandi, S; Panigrahi, D; Pattanaik, KP; Swain, R; Swain, SS | 1 |
| Liang, Y; Ren, K; Xu, XD; Zhao, GJ | 1 |
| Balan, A; Bobescu, E; Covaciu, A; Dima, L; Marceanu, LG; Strempel, CG | 1 |
| Li, L; Su, Q; Sun, Y; Yang, H; Zhao, J | 1 |
| Avcı, B; Çavun, S; Savcı, V; Şentürk, T; Serdar, Z; Yermezler, A | 1 |
| Al-Aubaidy, HA; Amber, KI; Hadi, NR; Jamil, DA; Muhammad-Baqir, BM | 1 |
| Assunção, CR; Carvalho, KG; Jessen, B; Martins, GF; Santos, JB; Siqueira Filho, AG; Valência, A; Vieira, FB | 1 |
| Chen, J; Li, C; Xu, W; Zhou, X | 1 |
| Barsotti, A; Di Napoli, P | 1 |
| Abdel-Salam, OM; El-Batran, S | 1 |
| Altekin, E; Goldeli, O; Kuralay, F; Onvural, B; Yazlar, AS | 1 |
1 review(s) available for trimetazidine and Inflammation
| Article | Year |
|---|---|
[Trimetazidine and cardioprotection during ischemia-reperfusion].
Topics: Humans; Inflammation; Microcirculation; Myocardial Reperfusion Injury; Trimetazidine; Vasodilator Agents | 2004 |
3 trial(s) available for trimetazidine and Inflammation
| Article | Year |
|---|---|
The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients.
Topics: Angina Pectoris; Cardiomyopathies; Fibrosis; Humans; Inflammation; Myocardial Ischemia; Trimetazidine; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2023 |
Trimetazidine attenuates the acute inflammatory response induced by Novolimus eluting bioresorbable coronary scaffold implantation.
Topics: Absorbable Implants; Adult; Aged; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Inflammation; Inflammation Mediators; Macrolides; Male; Middle Aged; Percutaneous Coronary Intervention; Single-Blind Method; Tissue Scaffolds; Trimetazidine; Vasodilator Agents | 2016 |
Trimetazidine and inflammatory response in coronary artery bypass grafting.
Topics: Aged; Biomarkers; Coronary Artery Bypass; Cytokines; Double-Blind Method; Female; Humans; Inflammation; Inflammation Mediators; Male; Placebos; Postoperative Period; Prospective Studies; Time Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2012 |
13 other study(ies) available for trimetazidine and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Trimetazidine Alleviates Postresuscitation Myocardial Dysfunction and Improves 96-Hour Survival in a Ventricular Fibrillation Rat Model.
Topics: Animals; Biomarkers; Cardiomyopathies; Cardiopulmonary Resuscitation; Inflammation; Rats; Rats, Sprague-Dawley; Stroke Volume; Trimetazidine; Ventricular Fibrillation; Ventricular Function, Left | 2022 |
Trimetazidine attenuates cyclophosphamide-induced cystitis by inhibiting TLR4-mediated NFκB signaling in mice.
Topics: Animals; Antioxidants; Cyclophosphamide; Cystitis; Inflammation; Mesna; Mice; Mice, Inbred BALB C; NF-kappa B; Toll-Like Receptor 4; Trimetazidine | 2022 |
The protective effects of trimetazidine against ovary ischemia-reperfusion injury via the TLR4/Nf-kB signal pathway.
Topics: Animals; Female; Inflammation; Ischemia; NF-kappa B; Ovary; Rats; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4; Trimetazidine | 2022 |
Gentiopicroside enhances the protective effect of trimetazidine against myocardial ischemia-reperfusion injury via the AMPK/NLRP3 inflammasome signaling.
Topics: AMP-Activated Protein Kinases; Animals; Inflammasomes; Inflammation; Myocardial Reperfusion Injury; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Trimetazidine | 2023 |
Bentonite-in hypromellose-poloxamer sol-gel for corneal application of trimetazidine: Study of rheology and ocular anti inflammatory potential.
Topics: Animals; Anti-Inflammatory Agents; Bentonite; Carrageenan; Cornea; Drug Delivery Systems; Gels; Hypromellose Derivatives; Inflammation; Poloxamer; Rabbits; Rheology; Trimetazidine | 2023 |
Trimetazidine attenuates diabetic inflammation via Nrf2 activation.
Topics: Diabetes Mellitus; Humans; Inflammation; NF-E2-Related Factor 2; Trimetazidine; Vasodilator Agents | 2020 |
Trimetazidine Therapy in Coronary Artery Disease: The Impact on Oxidative Stress, Inflammation, Endothelial Dysfunction, and Long-Term Prognosis.
Topics: Acute Coronary Syndrome; Coronary Artery Disease; Humans; Inflammation; Oxidative Stress; Prognosis; Prospective Studies; Trimetazidine | 2021 |
Effects of Trimetazidine on PDCD4/NF-κB/TNF-α Pathway in Coronary Microembolization.
Topics: Animals; Apoptosis Regulatory Proteins; Coronary Vessels; Disease Models, Animal; Echocardiography; Embolism; Heart Injuries; Humans; Inflammation; Male; Myocardium; Myocytes, Cardiac; Percutaneous Coronary Intervention; RNA-Binding Proteins; Signal Transduction; Swine; Swine, Miniature; Transcription Factor RelA; Trimetazidine; Tumor Necrosis Factor-alpha | 2017 |
Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury.
Topics: Acetylcysteine; Animals; Apoptosis; Blood Pressure; Caspase 3; Cell Death; Coronary Vessels; Disease Models, Animal; Fatty Acids; Glucose; Glutathione; Inflammation; Male; Malondialdehyde; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Oxidative Stress; Oxygen; Rats; Rats, Wistar; Reperfusion Injury; S100 Calcium Binding Protein beta Subunit; Trimetazidine | 2014 |
Trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation.
Topics: Animals; Apoptosis; Cardiomyopathies; Cardiotonic Agents; Cytokines; Drug Evaluation, Preclinical; Gene Expression Regulation; Inflammation; Inflammation Mediators; Male; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Wistar; Smoking; Trimetazidine; Vasodilator Agents; Ventricular Remodeling | 2012 |
Pharmacological investigation of trimetazidine in models of inflammation, pain and gastric injury in rodents.
Topics: Acute Disease; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Edema; Gastric Acid; Indomethacin; Inflammation; Mice; Pain; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Trimetazidine | 2005 |
Suppression of angioplasty-related inflammation by pre-procedural treatment with trimetazidine.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitrates; Nitrites; Reactive Oxygen Species; Time Factors; Treatment Outcome; Trimetazidine; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2006 |